Arca
Skip to content
Tools
Tools

Spectranectics CVX-300 Excimer Laser System

Device, angioplasty, laser, coronary. PMA P910001, from Spectranetics Corp. (Colorado Springs, CO). Product code LPC, class 3.

As of Nov 19, 2026, P910001 is an FDA PMA held by Spectranetics Corp., approved on Feb 19, 1993 after 742 days, with no recalls tied to it in FDA's recall database.

  • Review time: 742 days
  • Supplements: 114
  • Recalls: 0
  • Cited as a predicate by: 1 device

What FDA approved

FDA's approval order statement

Approval for the spectranetics cvx-300(TM) excimer laser system, including the models pc1014 and pc1017 laser catheters. This system is indicated for use in patients with single or multivessel coronary artery disease either as a stand alone modality or in conjunction with percutaneous transluminal coronary balloon angioplasty (PTCA) and who are acceptable candidates for coronary artery bypass graft (CABG) surgery. Adjunctive balloon angioplasty was performed, at the clinical investigator's discretion, in 84 percent of the lesions treated. Clinical experience has provided reasonable assurance that the spectraneticics cvx-300(TM) excimer laser system and multifiber laser catheters are safe and effective for the following indications:occluded saphenous vein bypass grafts; ostial lesions; long lesions (greater than 20 mm in length); moderately calcified stenoses (heavily calcified stenoses…

Cited as a predicate

1 later 510(k) summary names this device as a predicate

Supplements

114 supplements to this PMA; the 15 newest
Aug 21, 2026S127Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Aug 14, 2026S126Process Change - Manufacturer/Sterilizer/Packager/Supplier135 Review Track For 30-Day Notice
Feb 6, 2026S124Process Change - Manufacturer/Sterilizer/Packager/Supplier135 Review Track For 30-Day Notice
Dec 18, 2025S125Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Nov 21, 2024S123Change Design/Components/Specifications/MaterialReal-Time Process
Sep 5, 2024S122Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Oct 30, 2023S121Change Design/Components/Specifications/MaterialReal-Time Process
Aug 31, 2023S120Change Design/Components/Specifications/MaterialReal-Time Process
May 4, 2023S119Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Mar 21, 2023S118Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Oct 21, 2022S117Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Aug 19, 2022S116Process Change - Manufacturer/Sterilizer/Packager/SupplierReal-Time Process
May 5, 2022S115Change Design/Components/Specifications/MaterialReal-Time Process
Feb 24, 2022S114Process Change - Manufacturer/Sterilizer/Packager/SupplierSpecial (Immediate Track)
Sep 2, 2021S112Change Design/Components/Specifications/MaterialNormal 180 Day Track

Record

Type
Original PMA
Received
Feb 8, 1991
Review panel
Cardiovascular

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.